Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 MutationsDavid M. Hyman, José Baselga, Jürgen Wolf et al.|New England Journal of Medicine|2015Cited by 1.7k
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trialAimery de Gramont, Paulo M. Hoff, Eric Van Cutsem et al.|The Lancet Oncology|2012Cited by 526
BRAF Inhibition in <i>BRAF</i> <sup>V600</sup> -Mutant Gliomas: Results From the VE-BASKET StudyThomas Kaley, David M. Hyman, Mehdi Touat et al.|Journal of Clinical Oncology|2018Cited by 330